News summary

Prognostic value of the Osaka Prognostic Score for two-year mortality in patients with heart failure with reduced ejection fraction

Source: Frontiers - Health • Published: 05 Nov 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Retrospective study found OPS associated with two-year all-cause mortality in HFrEF.

Prognostic value of the Osaka Prognostic Score for two-year mortality in patients with heart failure with reduced ejection fraction
Key Takeaways
  • Higher OPS was associated with greater two-year mortality risk.
  • OPS is based on CRP, albumin, and lymphocyte count.
  • This is observational and causal effect remains unproven.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.